OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
DNK.NH58

Danakali Ltd

Diversified ChemicalsVerified

Danakali's capital structure is characterized by a current ratio of 62.63, indicating strong liquidity with current assets significantly outpacing current liabilities. The company has no long-term debt, and its debt-to-equity ratio is 0.0, reflecting a conservative leverage profile. However, the company has a negative operating cash flow of -1.795 million AUD and a free cash flow of -1.905 million AUD, suggesting ongoing cash burn. Profitability metrics are negative, with a return on equity of -6.77% and a return on assets of -6.64%. These figures are below the industry median for Diversified Chemicals, which typically shows positive returns in stable market conditions. The company's operating income of -1.939 million AUD and net income of -1.954 million AUD further underscore its unprofitable operations. Geographically, Danakali's revenue is concentrated in Australia and the Arabian-Nubian Shield, with a significant portion tied to its joint venture in Saudi Arabia. The company's exploration activities are primarily in early-stage projects, and it has not disclosed segment-specific revenue figures. This lack of diversification increases exposure to regional and commodity price volatility. The company's growth trajectory is uncertain, with no disclosed revenue growth in the current fiscal year. The outlook for the next fiscal year is not quantified, but the company's ongoing losses and negative cash flows suggest a challenging path to profitability. Capital expenditures are minimal at -10,360 AUD, indicating limited near-term investment in expansion. Risk factors include liquidity concerns due to negative net cash after subtracting total debt, despite the high current ratio. The company's low dilution risk is offset by the potential for future equity issuance to fund operations. The risk assessment highlights the need for close monitoring of cash flow trends and capital structure adjustments. Recent events include the signing of a joint venture agreement with Massadir Al-Zamrda for emerald exploration in Saudi Arabia, which could provide a new revenue stream. However, the company has not disclosed any recent filings or transcripts that would indicate significant operational or strategic changes.

30-day price · DNK.NH-0.00 (-2.2%)
Low$0.04High$0.05Close$0.04As of13 May, 00:00 UTC
Profile
CompanyDanakali Ltd
TickerDNK.NH
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryDiversified Chemicals
AI analysis

Business. Danakali Limited is an Australia-based precious and critical mineral exploration and development company focused on assets in the Arabian-Nubian Shield and Australia, with an 80% interest in a joint venture for emerald exploration in Saudi Arabia.

Classification. Danakali is classified under the Basic Materials economic sector, Chemicals business sector, and Diversified Chemicals industry with a confidence level of 0.92.

Danakali's capital structure is characterized by a current ratio of 62.63, indicating strong liquidity with current assets significantly outpacing current liabilities. The company has no long-term debt, and its debt-to-equity ratio is 0.0, reflecting a conservative leverage profile. However, the company has a negative operating cash flow of -1.795 million AUD and a free cash flow of -1.905 million AUD, suggesting ongoing cash burn. Profitability metrics are negative, with a return on equity of -6.77% and a return on assets of -6.64%. These figures are below the industry median for Diversified Chemicals, which typically shows positive returns in stable market conditions. The company's operating income of -1.939 million AUD and net income of -1.954 million AUD further underscore its unprofitable operations. Geographically, Danakali's revenue is concentrated in Australia and the Arabian-Nubian Shield, with a significant portion tied to its joint venture in Saudi Arabia. The company's exploration activities are primarily in early-stage projects, and it has not disclosed segment-specific revenue figures. This lack of diversification increases exposure to regional and commodity price volatility. The company's growth trajectory is uncertain, with no disclosed revenue growth in the current fiscal year. The outlook for the next fiscal year is not quantified, but the company's ongoing losses and negative cash flows suggest a challenging path to profitability. Capital expenditures are minimal at -10,360 AUD, indicating limited near-term investment in expansion. Risk factors include liquidity concerns due to negative net cash after subtracting total debt, despite the high current ratio. The company's low dilution risk is offset by the potential for future equity issuance to fund operations. The risk assessment highlights the need for close monitoring of cash flow trends and capital structure adjustments. Recent events include the signing of a joint venture agreement with Massadir Al-Zamrda for emerald exploration in Saudi Arabia, which could provide a new revenue stream. However, the company has not disclosed any recent filings or transcripts that would indicate significant operational or strategic changes.
Key takeaways
  • Danakali has a strong liquidity position with a current ratio of 62.63 but is unprofitable with negative returns on equity and assets.
  • The company's operations are concentrated in early-stage exploration projects in Australia and the Arabian-Nubian Shield.
  • No long-term debt and a debt-to-equity ratio of 0.0 indicate a conservative capital structure.
  • The company's growth trajectory is uncertain, with no disclosed revenue growth and minimal capital expenditures.
  • The risk assessment highlights liquidity concerns and the potential for future equity issuance.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyAUD
Revenue$1.3M
Gross profit
Operating income-$1.9M
Net income-$2.0M
R&D
SG&A
D&A
SBC
Operating cash flow-$1.8M
CapEx-$10.4k
Free cash flow-$1.9M
Total assets$29.4M
Total liabilities$551.9k
Total equity$28.9M
Cash & equivalents
Long-term debt$102.1k
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$28.9M
Net cash-$102.1k
Current ratio62.6
Debt/Equity0.0
ROA-6.6%
ROE-6.8%
Cash conversion92.0%
CapEx/Revenue-0.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Diversified Chemicals · cohort 80 companies
MetricDNK.NHActivity
Op margin-150.5%-1.1% medp25 -1.1% · p75 -1.1%bottom quartile
Net margin-151.7%-6.6% medp25 -6.6% · p75 -6.6%bottom quartile
Gross margin12.9% medp25 12.9% · p75 12.9%
R&D / revenue1.9% medp25 1.9% · p75 1.9%
CapEx / revenue-0.8%-7.1% medp25 -12.7% · p75 -4.4%top quartile
Debt / equity0.0%1639.6% medp25 1639.6% · p75 1639.6%bottom quartile
Observations
IR observations
market data ESG controversies score100.0
market data ESG governance pillar18.9
market data ESG social pillar22.8
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 23:44 UTC#16d1dff3
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 23:46 UTCJob: 4cb75668